Page last updated: 2024-11-05

4-deethylatrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

desethylatrazine: a chlorotriazine herbicide; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

deethylatrazine : A chloro-1,3,5-triazine that is 6-chloro-1,3,5-triazine-2,4-diamine in which one of the hydrogens of the amino group is replaced by a propan-2-yl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID22563
CHEMBL ID3184909
CHEBI ID28212
SCHEMBL ID1425222
MeSH IDM0090231

Synonyms (75)

Synonym
2-amino-4-isopropylamino-6-chloro-s-triazine
desisopropyl propazine
6-chloro-n-(1-methylethyl)-1,3,5-triazine-2,4-diamine
6-chloro-n-(propan-2-yl)-1,3,5-triazine-2,4-diamine
4-deethylatrazine
desethyl atrazine
deethylatrazin
6-chloro-n-isopropyl-1,3,5-triazine-2,4-diamine
CHEBI:28212 ,
2-chloro-4-amino-6-(isopropylamino)-s-triazine
2-amino-4-chloro-6-(isopropylamino)-s-triazine
6190-65-4
C06559
deethylatrazine
NCGC00163770-02
NCGC00163770-01
1,3,5-triazine-2,4-diamine, 6-chloro-n-(1-methylethyl)-
des-ethyl atrazine
s-triazine, 2-amino-4-chloro-6-(isopropylamino)-
g 30033
ccris 3555
hsdb 2672
2-chloro-4-amino-6-isopropylamino-s-triazine
ciat
6-chloro-2-n-propan-2-yl-1,3,5-triazine-2,4-diamine
FT-0661868
AKOS004119348
NCGC00163770-03
NCGC00163770-05
NCGC00163770-04
2-amino-4-chloro-6-(isopropylamino)-1,3,5-triazine
dtxcid3017494
dtxsid5037494 ,
NCGC00254972-01
tox21_301071
cas-6190-65-4
2-chloro-isopropylamino-1,3,5-triazine
2-amino-4-(isopropylamino)-6-chloro-1,3,5-triazine
2-chloro-4-isopropylamino-6-amino-s-triazine
unii-07pv14bk6x
07pv14bk6x ,
desethylatrazine
desethyl atrazine [hsdb]
6-amino-2-chloro-4-isopropylamino-s-triazine
s-chloroaminoisopropylaminotriazine
1,3,5-triazine-2,4-diamine, 6-chloro-n2-(1-methylethyl)-
atrazine-desethyl
n-deethylatrazine
deethylatratone
g-30033
2-chloro-4-amino-6-isopropylamino-1,3,5-triazine
2-isopropylamino-4-amino-6-chloro-1,3,5-triazine
deethylatrazine, 4-
2-amino-4-chloro-6-isopropylamino-s-triazine
SCHEMBL1425222
atrazine desethyl
DFWFIQKMSFGDCQ-UHFFFAOYSA-N
2-amino-4-isopropylamino-6-chlorotriazine
CHEMBL3184909
6-chloro-2-n-(propan-2-yl)-1,3,5-triazine-2,4-diamine
atrazine-desethyl, pestanal(r), analytical standard
atrazine-desethyl, analytical standard
atrazine-desethyl 10 microg/ml in acetonitrile
atrazine-desethyl 100 microg/ml in acetonitrile
atrazine-desethyl 100 microg/ml in cyclohexane
2-amino-4-chloro-6-isopropylamino-1,3,5-triazine
desethyl-atrazine
atrazine m (des-ethyl)
6-chloro-n-(1-methylethyl)-1,3,5-triazine-2,4-diamine, 9ci
deethyatrazine
6-chloro-n2-isopropyl-1,3,5-triazine-2,4-diamine
atrazine tp2
Q22330060
SB73302
CS-0454252

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" To better understand the toxicokinetics of ATR and to fill the need for a mouse model, a physiologically based pharmacokinetic (PBPK) model for ATR and its main chlorotriazine metabolites (Cl-TRIs) desethyl atrazine (DE), desisopropyl atrazine (DIP), and didealkyl atrazine (DACT) was developed for the adult male C57BL/6 mouse."( A physiologically based pharmacokinetic model for atrazine and its main metabolites in the adult male C57BL/6 mouse.
Filipov, NM; Fisher, JW; Lin, Z; Ross, MK, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
" An adequate description of the uptake and bioavailability of absorbed ATRA also required inclusion of additional oxidative metabolic clearance of ATRA to the mono-dealkylated metabolites occurring in GI a tract compartment."( Oral absorption and oxidative metabolism of atrazine in rats evaluated by physiological modeling approaches.
Andersen, ME; Cranmer, BK; Hanneman, WH; McMullin, TS; Tessari, JD, 2007
)
0.34
"An extensive four-year research program has been carried out to explore and acquire knowledge about the fundamental agricultural practices and processes affecting the mobility and bioavailability of pesticides in soils under semi-arid Mediterranean conditions."( Leaching of Br-, metolachlor, alachlor, atrazine, deethylatrazine and deisopropylatrazine in clayey vadoze zone: a field scale experiment in north-east Greece.
Papadakis, EN; Papadopoulou-Mourkidou, E; Vryzas, Z, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
" Here, we develop a set of physiologically based pharmacokinetic (PBPK) models that describe the influence of oral absorption and oxidative metabolism on the blood time course curves of individual chlorotriazines (Cl-TRIs) in rat after oral dosing of ATRA."( Oral absorption and oxidative metabolism of atrazine in rats evaluated by physiological modeling approaches.
Andersen, ME; Cranmer, BK; Hanneman, WH; McMullin, TS; Tessari, JD, 2007
)
0.34
" Temperature increase did not change SMOC toxicity but modify the shape and steepness of the dose-response curve."( Individual and joint toxicity of the herbicide S-metolachlor and a metabolite, deethylatrazine on aquatic crustaceans: Difference between ecological groups.
Baran, N; Coureau, C; Maazouzi, C; Marmonier, P; Piscart, C; Saplairoles, M, 2016
)
0.43
" Intracerebroventricular infusion of ATR, DEA, and DIA but not DACT at concentrations equivalent to peak plasma concentrations after gavage dosing resulted in an elevation of plasma corticosterone concentrations."( Characterization of Activation of the Hypothalamic-Pituitary-Adrenal Axis by the Herbicide Atrazine in the Female Rat.
Breckenridge, CB; Foradori, CD; Handa, RJ; Healy, JE; Hinds, LR; Jones, MA; Kemppainen, RJ; Lacagnina, AF; Quihuis, AM; Read, CC; White, BD; Yi, KD; Zimmerman, AD, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
marine xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
chloro-1,3,5-triazineA member of the class of 1,3,5-triazines that is 1,3,5-triazine substituted by at least one chloro group at unspecified position.
diamino-1,3,5-triazineAny member of the class of 1,3,5-triazines that consists of a 1,3,5-triazine skeleton substituted by two amino groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
atrazine degradation II07

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency10.65590.000714.592883.7951AID1259369; AID1259392
retinoid X nuclear receptor alphaHomo sapiens (human)Potency48.88240.000817.505159.3239AID1159531
aryl hydrocarbon receptorHomo sapiens (human)Potency76.80230.000723.06741,258.9301AID743085
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency22.71950.000323.4451159.6830AID743065; AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (66)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.03)18.7374
1990's5 (7.58)18.2507
2000's29 (43.94)29.6817
2010's25 (37.88)24.3611
2020's5 (7.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.87 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other73 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]